LP
CLB icon

LMR Partners’s Core Laboratories CLB Stock Holding History

LMR Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-272,380
Closed -$4.81M – 1173
2023
Q4 		$4.81M Sell
272,380
-164,774
-38% -$3.32M 0.05% 312
2023
Q3 		$10.5M Buy
+437,154
New +$10.7M 0.12% 182
2023
Q1 		– Sell
-223,311
Closed -$4.53M – 1045
2022
Q4 		$4.53M Buy
+223,311
New +$4.33M 0.08% 289
2022
Q2 		– Sell
-54,369
Closed -$1.72M – 1311
2022
Q1 		$1.72M Buy
54,369
+11,498
+27% +$322K 0.02% 621
2021
Q4 		$956K Buy
42,871
+6,600
+18% +$172K 0.01% 753
2021
Q3 		$1.01M Hold
36,271
– – 0.01% 618
2021
Q2 		$1.41M Buy
+36,271
New +$1.3M 0.02% 456
2018
Q2 		– Sell
-48,094
Closed -$5.27M – 493
2018
Q1 		$5.27M Hold
48,094
– – 0.54% 29
2017
Q4 		$5.27M Buy
+48,094
New +$4.8M 0.54% 29

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

LMR Partners's CLB Position: Q1 2024 in Review

LMR Partners sold out of Core Laboratories (CLB) in Q1 2024, closing a stake of 272,380 shares — an estimated $4.81M sold.

LMR Partners first reported a position in CLB in Q4 2017 and held it in 9 quarters. The position peaked at $10.5M in Q3 2023. 197 funds tracked by Wall St. Rank hold CLB as of Q1 2024.

  • LMR Partners reported no remaining Core Laboratories position as of Q1 2024 after selling out during the quarter.
  • LMR Partners sold 272,380 Core Laboratories shares in Q1 2024, an estimated $4.81M.
  • LMR Partners first reported a position in Core Laboratories in Q4 2017 and held it in 9 quarters.
  • LMR Partners's Core Laboratories position peaked at $10.5M in Q3 2023.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.